A series of 4-(substituted pyridyl)-l,4-dihydropyridine derivatives were synthesized and their hypotensive effects examined. Several compounds, 2-(A-benzyl-A-methylamino)ethyl methyl l,4-dihydro-2,6-dimethyl-4-(3-nitro-2-pyridyl)-3,5-pyridinedicarboxylate (2b), its 4-(4-nitro-2-pyridyl) analogue (2g), 4-(3-trifluoromethyl-2-pyridyl) analogue (2c), 4-(2-trifluoromethyl-3-pyridyl) analogue (3e), 4-(4-cyano-2-pyridyl) analogue (2e), 4-(2-cyano-3-pyridyl) analogue (3d), and 4-(6-bromo-2-pyridyl) analogue (2i), were found to have a hypotensive activity parallel to that of nicardipine; 2c and 3e, in particular, had approximately twice the duration of nicardipine, and 2e had the most potent hypotensive activity of all the derivatives synthesized. © 1990, The Pharmaceutical Society of Japan. All rights reserved.
CITATION STYLE
Ashimori, A., Ono, T., Uchida, T., Ohtaki, Y., Fukaya, C., Yokoyama, K., & Watanabe, M. (1990). Novel 1,4-Dihydropyridine Calcium Antagonists. I. Synthesis and Hypotensive Activity of 4-(Substituted Pyridyl)-l,4-dihydropyridine Derivatives. Chemical and Pharmaceutical Bulletin, 38(9), 2446–2458. https://doi.org/10.1248/cpb.38.2446
Mendeley helps you to discover research relevant for your work.